Telfast Oral Liquid Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

telfast oral liquid

pharmacy retailing (nz) ltd t/a healthcare logistics - fexofenadine hydrochloride 6 mg/ml; fexofenadine hydrochloride 6 mg/ml - oral suspension - 6 mg/ml - active: fexofenadine hydrochloride 6 mg/ml excipient: butyl hydroxybenzoate dibasic sodium phosphate heptahydrate disodium edetate monobasic sodium phosphate monohydrate poloxamer propyl hydroxybenzoate propylene glycol purified water raspberry flavour f-9950 pfc sucrose titanium dioxide xanthan gum xylitol active: fexofenadine hydrochloride 6 mg/ml excipient: dibasic sodium phosphate heptahydrate disodium edetate monobasic sodium phosphate monohydrate poloxamer potassium sorbate propylene glycol purified water raspberry flavour f-9950 pfc sucrose titanium dioxide xanthan gum xylitol - relief of symptoms associated with seasonal allergic rhinitis and allergic rhinitis in adults and children from 2 years of age.

CONTRAVE EXTENDED-RELEASE- naltrexone hydrochloride and bupropion hydrochloride tablet, extended release Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

contrave extended-release- naltrexone hydrochloride and bupropion hydrochloride tablet, extended release

a-s medication solutions - naltrexone hydrochloride (unii: z6375yw9sf) (naltrexone - unii:5s6w795cqm), bupropion hydrochloride (unii: zg7e5poy8o) (bupropion - unii:01zg3tpx31) - contrave is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (bmi) of: - 30 kg/m2 or greater (obese) or - 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia). limitations of use: - the effect of contrave on cardiovascular morbidity and mortality has not been established. - the safety and effectiveness of contrave in combination with other products intended for weight loss, including prescription drugs, over-the-counter drugs, and herbal preparations, have not been established. contrave is contraindicated in - uncontrolled hypertension [see warnings and precautions (5.5)] - seizure disorder or a history of seizures [see warnings and precautions (5.3)] - use of other bupropion-containing products (including, but not limited to, wellbutrin, wellbutrin sr, wellbutrin xl, aplenzin and zyban) - bulimi

Contrave 8/90 Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

contrave 8/90

inova pharmaceuticals (new zealand) limited - bupropion hydrochloride 90mg equivalent to bupropion 78mg;  ;  ; naltrexone hydrochloride 8mg equivalent to naltrexone 7.2mg;   - modified release tablet - active: bupropion hydrochloride 90mg equivalent to bupropion 78mg     naltrexone hydrochloride 8mg equivalent to naltrexone 7.2mg   excipient: colloidal silicon dioxide crospovidone cysteine hydrochloride monohydrate disodium edetate hyprolose hypromellose indigo carmine aluminium lake lactose lactose monohydrate magnesium stearate microcrystalline cellulose opadry blue 85f90663 - contrave is indicated, as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients (>/= 18 years) with an initial body mass index (bmi) of: · >/= 30 kg/m2 (obese), or · >/= 27 kg/m2 to < 30 kg/m2 (overweight) in the presence of one or more weight-related co-morbidities (e.g., type 2 diabetes, dyslipidaemia, or controlled hypertension). treatment with contrave should be discontinued after 16 weeks if patients have not lost at least 5% of their initial body weight.

CONTROL-A-BIRD AGENT Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

control-a-bird agent

control a bird pty limited - fenthion - paint - fenthion organophosphorus active 110.0 g/kg - vertebrate poison - agricultural/farm buildings | building | commercial/industrial premises | processing and manufacturing plants | shed,factory,war - indian myna | pigeon | sparrow | starling | myna birds

CONTROL-A-BIRD BIRD REPELLENT - SEE 42202 Austraalia - inglise - APVMA (Australian Pesticides and Veterinary Medicines Authority)

control-a-bird bird repellent - see 42202

control a bird pty limited - fenthion - miscellaneous - farm and/or animal housing | food processing and/or preserving plant | pest c. institutional, business premises | pest control - - pigeon | sparrow | starling

JARDIANCE DUO 12.5 MG500 MG Iisrael - inglise - Ministry of Health

jardiance duo 12.5 mg500 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 12.5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

JARDIANCE DUO 5 MG500 MG Iisrael - inglise - Ministry of Health

jardiance duo 5 mg500 mg

boehringer ingelheim israel ltd. - empagliflozin; metformin hydrochloride - film coated tablets - empagliflozin 5 mg; metformin hydrochloride 500 mg - metformin and empagliflozin - jardiance duo is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control• in patients inadequately controlled on their maximally tolerated dose of metformin alone.• in patients inadequately controlled with metformin in combination with other glucose-lowering medicinal products, including insulin.• in patients already being treated with the combination of empagliflozin and metformin as separate tablets.

VIMOVO TABLET (IMMEDIATE AND DELAYED-RELEASE) Kanada - inglise - Health Canada

vimovo tablet (immediate and delayed-release)

xediton pharmaceuticals inc - naproxen; esomeprazole (esomeprazole magnesium trihydrate) - tablet (immediate and delayed-release) - 375mg; 20mg - naproxen 375mg; esomeprazole (esomeprazole magnesium trihydrate) 20mg - other nonsteroidal antiimflammatory agents